Pfizer Inc’s recent filing unveils that its Former Officer Dolsten Mikael acquired Company’s shares for reported $1.38 million on May 23 ’25. In the deal valued at $23.09 per share,59,781 shares were bought.
Then, Dolsten Mikael bought 55,000 shares, generating $1,312,736 in total proceeds.
Before that, DAMICO JENNIFER B. sold 2,500 shares. Pfizer Inc shares valued at $64,825 were divested by the SVP & Controller at a price of $25.93 per share. As a result of the transaction, DAMICO JENNIFER B. now holds 11,850 shares, worth roughly $0.28 million.
Cantor Fitzgerald initiated its Pfizer Inc [PFE] rating to a Neutral in a research note published on April 22, 2025; the price target was $24. Wolfe Research began covering PFE with “an Underperform” recommendation on November 15, 2024.
Price Performance Review of PFE
On Friday, Pfizer Inc [NYSE:PFE] saw its stock jump 0.17% to $23.49. Over the last five days, the stock has gained 1.95%. Pfizer Inc shares have fallen nearly -11.46% since the year began. Nevertheless, the stocks have fallen -17.00% over the past one year. While a 52-week high of $31.54 was reached on 01/07/25, a 52-week low of $20.92 was recorded on 04/09/25. SMA at 50 days reached $23.41, while 200 days put it at $26.30.
Levels Of Support And Resistance For PFE Stock
The 24-hour chart illustrates a support level at 23.23, which if violated will result in even more drops to 22.96. On the upside, there is a resistance level at 23.69. A further resistance level may holdings at 23.88. The Relative Strength Index (RSI) on the 14-day chart is 52.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.14%. Stochastics %K at 81.12% indicates the stock is a selling.
The most recent change occurred on October 17, 2024 when Bernstein began covering the stock and recommended ‘”a Mkt perform”‘ rating along with a $32 price target.
